Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02663544 · ClinicalTrials.gov registry record · NA

The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)

A NA study of Obesity and Diabetes, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT02663544: Completed NA study of Obesity and Diabetes, sponsored by Fred Hutchinson Cancer Center.

NCT02663544 is a NA study of Obesity and Diabetes that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 72 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02663544, a NA study of Obesity and Diabetes, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled feeding trial aims to determine whether the consumption of different amounts and types of dairy products affects blood sugar regulation and cardiometabolic health in men and women with the metabolic syndrome.

Primary Outcome

As measured by glucose area under the curve during a frequently sampled 3-hour oral glucose tolerance test (FS-OGTT).

Interventions

  • OTHER Limited dairy diet
  • OTHER Low-fat dairy diet
  • OTHER Full-fat dairy diet

Study Locations (1)

Washington

  • Fred Hutchinson Cancer Research Center - Seattle

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2016-01
Est. Completion 2018-10-18
Phase NA
Fred Hutchinson Cancer Center

483 total trials

What the finished NCT02663544 record still lists

NCT02663544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).

The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Limited dairy diet is the first listed.

NCT02663544 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02663544 about?

NCT02663544 is a clinical study titled "The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)". This randomized controlled feeding trial aims to determine whether the consumption of different amounts and types of dairy products affects blood sugar regulation and cardiometabolic health in men and women with the metabolic syndrome.

What is the current status of trial NCT02663544?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2016-01. Estimated completion is 2018-10-18.

What conditions does trial NCT02663544 study?

This clinical trial studies the following conditions: Obesity, Diabetes, Inflammation, Insulin Resistance, Metabolic Syndrome.

What interventions are being tested in trial NCT02663544?

The interventions under investigation include: Limited dairy diet (OTHER), Low-fat dairy diet (OTHER), Full-fat dairy diet (OTHER).

Who is sponsoring clinical trial NCT02663544?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02663544 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02663544's enrollment target sits among peer trials

72 583rd of 1053 higher than 462 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02663544, the US trial registry maintained by the National Library of Medicine. NCT02663544 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.